Document Detail

Fluoride tablet supplementation during pregnancy for caries immunity: a study of the offspring produced.
MedLine Citation:
PMID:  7091227     Owner:  NLM     Status:  MEDLINE    
Evidence continues to accumulate that the fetal nutritional need for the mineral fluoride begins early in pregnancy and that tablet supplementation is required during the last two trimesters to supply that need, since fluoridated water alone during pregnancy is not sufficient. This study of 492 children confirms the safety and efficacy of using a sodium fluoride tablet supplement, by means of which the obstetrician can help his pregnant patients produce children with superior teeth that are immune to decay.
F B Glenn; W D Glenn; R C Duncan
Related Documents :
6775377 - Rhesus and other blood group incompatibilities in pregnancy.
22457307 - Pregnancy-associated venous thrombosis.
1836497 - Cd4 to cd8 ratio and in vitro lymphoproliferative responses during experimental gingivi...
6161687 - Winrho: rh immune globulin prepared by ion exchange for intravenous use.
2330587 - Preliminary evidence for a cocaine-induced embryopathy in mice.
518137 - Investigations of gestation-induced metabolic changes in the rat liver. i. glycogen met...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  143     ISSN:  0002-9378     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  1982 Jul 
Date Detail:
Created Date:  1982-08-14     Completed Date:  1982-08-14     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  560-4     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Administration, Oral
Child, Preschool
DMF Index
Dental Caries / prevention & control*
Fetus / physiology
Fluorides / administration & dosage,  adverse effects,  therapeutic use*
Reg. No./Substance:
0/Fluorides; 0/Tablets

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Midtrimester intrauterine exchange transfusion of the fetus.
Next Document:  Survival among women with endometrial cancer: a comparison of estrogen users and nonusers.